Ikarian Capital’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $490K | Hold |
106,901
| – | – | 0.09% | 64 |
|
|
2025
Q1 | $522K | Hold |
106,901
| – | – | 0.06% | 76 |
|
|
2024
Q4 | $718K | Buy |
106,901
+2
| +0% | +$13 | 0.1% | 77 |
|
|
2024
Q3 | $827K | Buy |
106,899
+20,000
| +23% | +$155K | 0.12% | 61 |
|
|
2024
Q2 | $521K | Hold |
86,899
| – | – | 0.09% | 69 |
|
|
2024
Q1 | $783K | Buy |
86,899
+1,560
| +2% | +$14.1K | 0.09% | 62 |
|
|
2023
Q4 | $809K | Hold |
85,339
| – | – | 0.08% | 55 |
|
|
2023
Q3 | $1.02M | Buy |
85,339
+1,179
| +1% | +$14K | 0.12% | 47 |
|
|
2023
Q2 | $2.06M | Hold |
84,160
| – | – | 0.33% | 32 |
|
|
2023
Q1 | $2.63M | Buy |
84,160
+21,161
| +34% | +$662K | 0.6% | 31 |
|
|
2022
Q4 | $4.44M | Sell |
62,999
-9,860
| -14% | -$694K | 1.07% | 21 |
|
|
2022
Q3 | $6.27M | Sell |
72,859
-67,953
| -48% | -$5.85M | 1.25% | 10 |
|
|
2022
Q2 | $11.6M | Buy |
140,812
+32,500
| +30% | +$2.69M | 2.12% | 5 |
|
|
2022
Q1 | $18M | Buy |
108,312
+6,220
| +6% | +$1.03M | 2.37% | 3 |
|
|
2021
Q4 | $17.1M | Buy |
+102,092
| New | +$17.1M | 2.54% | 2 |
|